U.S. flag

An official website of the United States government

NM_001370259.2(MEN1):c.660G>A (p.Trp220Ter) AND Multiple endocrine neoplasia, type 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 21, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001224068.8

Allele description [Variation Report for NM_001370259.2(MEN1):c.660G>A (p.Trp220Ter)]

NM_001370259.2(MEN1):c.660G>A (p.Trp220Ter)

Gene:
MEN1:menin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.1
Genomic location:
Preferred name:
NM_001370259.2(MEN1):c.660G>A (p.Trp220Ter)
HGVS:
  • NC_000011.10:g.64807675C>T
  • NG_008929.1:g.8620G>A
  • NG_033040.1:g.567G>A
  • NM_000244.4:c.675G>A
  • NM_001370251.2:c.660G>A
  • NM_001370259.2:c.660G>AMANE SELECT
  • NM_001370260.2:c.660G>A
  • NM_001370261.2:c.660G>A
  • NM_001370262.2:c.555G>A
  • NM_001370263.2:c.555G>A
  • NM_130799.3:c.660G>A
  • NM_130800.3:c.675G>A
  • NM_130801.3:c.675G>A
  • NM_130802.3:c.675G>A
  • NM_130803.3:c.675G>A
  • NM_130804.3:c.675G>A
  • NP_000235.3:p.Trp225Ter
  • NP_001357180.2:p.Trp220Ter
  • NP_001357188.2:p.Trp220Ter
  • NP_001357189.2:p.Trp220Ter
  • NP_001357190.2:p.Trp220Ter
  • NP_001357191.2:p.Trp185Ter
  • NP_001357192.2:p.Trp185Ter
  • NP_570711.1:p.Trp220Ter
  • NP_570711.2:p.Trp220Ter
  • NP_570712.2:p.Trp225Ter
  • NP_570713.2:p.Trp225Ter
  • NP_570714.2:p.Trp225Ter
  • NP_570715.2:p.Trp225Ter
  • NP_570716.2:p.Trp225Ter
  • LRG_509t2:c.660G>A
  • LRG_509:g.8620G>A
  • LRG_509p2:p.Trp220Ter
  • NC_000011.9:g.64575147C>T
  • NM_130799.2:c.660G>A
Protein change:
W185*
Links:
dbSNP: rs886039414
NCBI 1000 Genomes Browser:
rs886039414
Molecular consequence:
  • NM_000244.4:c.675G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001370251.2:c.660G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001370259.2:c.660G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001370260.2:c.660G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001370261.2:c.660G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001370262.2:c.555G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001370263.2:c.555G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_130799.3:c.660G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_130800.3:c.675G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_130801.3:c.675G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_130802.3:c.675G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_130803.3:c.675G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_130804.3:c.675G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Multiple endocrine neoplasia, type 1 (MEN1)
Synonyms:
MEA I; MEN I; Endocrine adenomatosis multiple; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007540; MeSH: D018761; MedGen: C0025267; Orphanet: 652; OMIM: 131100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001396245Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 21, 2020)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.

Schaaf L, Pickel J, Zinner K, Hering U, Höfler M, Goretzki PE, Spelsberg F, Raue F, von zur Mühlen A, Gerl H, Hensen J, Bartsch DK, Rothmund M, Schneyer U, Dralle H, Engelbach M, Karges W, Stalla GK, Höppner W.

Exp Clin Endocrinol Diabetes. 2007 Sep;115(8):509-17.

PubMed [citation]
PMID:
17853334

Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.

Teh BT, Kytölä S, Farnebo F, Bergman L, Wong FK, Weber G, Hayward N, Larsson C, Skogseid B, Beckers A, Phelan C, Edwards M, Epstein M, Alford F, Hurley D, Grimmond S, Silins G, Walters M, Stewart C, Cardinal J, Khodaei S, Parente F, et al.

J Clin Endocrinol Metab. 1998 Aug;83(8):2621-6.

PubMed [citation]
PMID:
9709921
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001396245.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MEN1 are known to be pathogenic (PMID: 12112656, 17853334). A different variant (c.659G>A) giving rise to the same protein effect observed here (p.Trp220*) has been determined to be pathogenic (PMID: 9709921). This suggests that this variant is also likely to be causative of disease. This variant has been observed in individuas affected with multiple endocrine neoplasia type 1 (PMID: 12112656, 15635078). ClinVar contains an entry for this variant (Variation ID: 265235). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp220*) in the MEN1 gene. It is expected to result in an absent or disrupted protein product.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024